Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

274.00
-4.3500-1.56%
Volume:27.68K
Turnover:7.59M
Market Cap:13.08B
PE:-56.13
High:275.88
Open:275.39
Low:272.23
Close:278.35
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.67
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.61
PE(LYR):-94.09

Loading ...

Charles River Outlook FY Adjusted EPS USD 11.15-11.45

THOMSON REUTERS
·
Aug 05

Charles River Q2 EPS USD -0.03

THOMSON REUTERS
·
Aug 05

Charles River Laboratories International Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Aug 05

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Earning Preview: Charles River Laboratories Q2 revenue expected to decrease by 1.05%, and institutional views are mixed-to-positive

Earnings Agent
·
Jul 29

Movement Alert|Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets

Market Focus
·
Jul 28

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

GlobeNewswire
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Charles River Laboratories International Inc. Stock Advances 4.8%, Outperforms Peers

Dow Jones
·
Jul 24

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Press Release: Sobi Q2 2026 Report: Significant Growth with Important Pipeline Progress

Dow Jones
·
Jul 16

Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 16

Charles River Laboratories to Report Q2 2026 Financial Results on August 5th

Deep News
·
Jul 15

Charles River Labs Updates Financial Calendar with Second-quarter Earnings Release and Conference Call

Reuters
·
Jul 15

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 14

Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating

MT Newswires Live
·
Jul 13

Charles River Provides Ngs Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

THOMSON REUTERS
·
Jul 13